Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell Carcinoma
Clinical trial NCT05984342 · RECRUITING
Trial details
- NCT number
- NCT05984342
- Sponsor
- Affiliated Cancer Hospital of Shantou University Medical College
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-02
- Primary completion
- 2025-06-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.